Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective study

Physical activity as a risk factor for prostate cancer diagnosis: a prospective biopsy cohort analysis

(2015) Cosimo De Nunzio et al.   BJU INTERNATIONAL

Dissecting the Association Between Metabolic Syndrome and Prostate Cancer Risk: Analysis of a Large Clinical Cohort

(2015) Bimal Bhindi et al.   EUROPEAN UROLOGY

Metabolic abnormalities linked to an increased cardiovascular risk are associated with high-grade prostate cancer: a single biopsy cohort analysis

(2015) C De Nunzio et al.   PROSTATE CANCER AND PROSTATIC DISEASES

The Metabolic Syndrome is Associated with More Aggressive Prostate Cancer

(2014) Emin Ozbek et al.   Asian Pacific Journal of Cancer Prevention

Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study

(2014) Katharine N. Sourbeer et al.   BJU INTERNATIONAL

Effect of metabolic syndrome and its components on prostate cancer risk: Meta-analysis

(2014) K. Esposito et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

The Relationship Between Prostate Cancer and Presence of Metabolic Syndrome and Late-onset Hypogonadism

(2014) Mustafa Kayali et al.   UROLOGY

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013

(2013) Axel Heidenreich et al.   EUROPEAN UROLOGY

The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence

(2013) Yu-zhu Xiang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Minireview: The Molecular and Genomic Basis for Prostate Cancer Health Disparities

(2013) Isaac J. Powell et al.   MOLECULAR ENDOCRINOLOGY

Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy

(2012) Jong Jin Oh et al.   BJU INTERNATIONAL

Metabolic syndrome increases the risk of aggressive prostate cancer detection

(2012) Juan Morote et al.   BJU INTERNATIONAL

Pre-treatment risk stratification of prostate cancer patients: A critical review

(2012) George Rodrigues et al.   CUAJ-Canadian Urological Association Journal

Effect of metabolic syndrome on pathologic features of prostate cancer

(2012) Emil Kheterpal et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume

(2011) Niall M. Corcoran et al.   BJU INTERNATIONAL

The Correlation Between Metabolic Syndrome and Prostatic Diseases

(2011) Cosimo De Nunzio et al.   EUROPEAN UROLOGY

Prostate cancer and inflammation: the evidence

(2011) Karen S Sfanos et al.   HISTOPATHOLOGY

Metabolic syndrome is associated with high grade gleason score when prostate cancer is diagnosed on biopsy

(2011) Cosimo De Nunzio et al.   PROSTATE

Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: A prospective multicenter Italian cohort study

(2011) Cosimo De Nunzio et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: results from the Olmsted County Study

(2010) Lauren P. Wallner et al.   BJU INTERNATIONAL

The Metabolic Syndrome and the Risk of Prostate Cancer under Competing Risks of Death from Other Causes

(2010) B. Grundmark et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Racial Differences in Risk of Prostate Cancer Associated With Metabolic Syndrome

(2009) Jennifer L. Beebe-Dimmer et al.   UROLOGY